Incidence of adverse cardiovascular events associated with immune checkpoint inhibitors and risk factors for left ventricular dysfunction: a single-center prospective clinical study

HIGHLIGHTS

• who: Chuan Zhang from the India Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China have published the paper: Incidence of adverse cardiovascular events associated with immune checkpoint inhibitors and risk factors for left ventricular dysfunction: A single-center prospective clinical study, in the Journal: (JOURNAL) of October/31,/2021
• what: Immune checkpoint inhibitors (ICI) can lead to a variety of ACEs, including acute myocarditis, pericardial effusion, LVD, ECG abnormalities, and cardiac biomarker abnormalities.
• how: Ethical approval and informed consent Cardiac function assessed by echocardiography This study was conducted . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.